TTPH - Tetraphase Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue18,9049,6665,14511,686
Cost of Revenue55,009101,70663,76473,768
Gross Profit-36,105-92,040-58,619-62,082
Operating Expenses
Research Development----
Selling General and Administrative37,07823,67519,21120,916
Non Recurring----
Others----
Total Operating Expenses92,185125,38182,97594,684
Operating Income or Loss-73,281-115,715-77,830-82,998
Income from Continuing Operations
Total Other Income/Expenses Net1,123963350-191
Earnings Before Interest and Taxes-73,281-115,715-77,830-82,998
Interest Expense-624-624-624-200
Income Before Tax-72,158-114,752-77,480-83,189
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-72,158-114,752-77,480-83,189
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-72,158-114,752-77,480-83,189
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-72,158-114,752-77,480-83,189